FusionNeoAntigen Logo

Home

Download

Statistics

Examples

Help

Contact

Terms of Use

Center for Computational Systems Medicine
leaf

Fusion Gene and Fusion Protein Summary

leaf

Fusion Amino Acid Sequences (multiple BPs and multiple gene isoforms)

leaf

Fusion Protein Breakpoint Sequences - (for the Screening of the FusionNeoAntigens)

leaf

Potential FusionNeoAntigens in HLA I - (netMHCpan v4.1 + deepHLApan v1.1)

leaf

Potential FusionNeoAntigens in HLA II - (netMHCIIpan v4.1)

leaf

Fusion Breakpoint 14 AA Peptide Structure - (RoseTTAFold)

leaf

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D - (Glide)

leaf

Vaccine Design for the FusionNeoAntigens (RNA/protein sequences)

leaf

Potential target of CAR-T therapy development

leaf

Information on the samples that have these potential fusion neoantigens

leaf

Fusion Protein Targeting Drugs - (Manual Curation)

leaf

Fusion Protein Related diseases - (Manual Curation)

Fusion Protein:SRGAP3-RAF1

Fusion Gene and Fusion Protein Summary

check button Fusion gene summary
Fusion partner gene informationFusion gene name: SRGAP3-RAF1
FusionPDB ID: 86395
FusionGDB2.0 ID: 86395
HgeneTgene
Gene symbol

SRGAP3

RAF1

Gene ID

23380

6037

Gene nameSLIT-ROBO Rho GTPase activating protein 2ribonuclease A family member 3
SynonymsARHGAP34|FNBP2|SRGAP2A|SRGAP3ECP|RAF1|RNS3
Cytomap

1q32.1

14q11.2

Type of geneprotein-codingprotein-coding
DescriptionSLIT-ROBO Rho GTPase-activating protein 2SLIT-ROBO GAP2formin-binding protein 2rho GTPase-activating protein 34eosinophil cationic proteinRNase 3cytotoxic ribonucleaseribonuclease 3ribonuclease, RNase A family, 3
Modification date2020031320200313
UniProtAcc.

P04049

Main function of 5'-partner protein: FUNCTION: Serine/threonine-protein kinase that acts as a regulatory link between the membrane-associated Ras GTPases and the MAPK/ERK cascade, and this critical regulatory link functions as a switch determining cell fate decisions including proliferation, differentiation, apoptosis, survival and oncogenic transformation. RAF1 activation initiates a mitogen-activated protein kinase (MAPK) cascade that comprises a sequential phosphorylation of the dual-specific MAPK kinases (MAP2K1/MEK1 and MAP2K2/MEK2) and the extracellular signal-regulated kinases (MAPK3/ERK1 and MAPK1/ERK2). The phosphorylated form of RAF1 (on residues Ser-338 and Ser-339, by PAK1) phosphorylates BAD/Bcl2-antagonist of cell death at 'Ser-75'. Phosphorylates adenylyl cyclases: ADCY2, ADCY5 and ADCY6, resulting in their activation. Phosphorylates PPP1R12A resulting in inhibition of the phosphatase activity. Phosphorylates TNNT2/cardiac muscle troponin T. Can promote NF-kB activation and inhibit signal transducers involved in motility (ROCK2), apoptosis (MAP3K5/ASK1 and STK3/MST2), proliferation and angiogenesis (RB1). Can protect cells from apoptosis also by translocating to the mitochondria where it binds BCL2 and displaces BAD/Bcl2-antagonist of cell death. Regulates Rho signaling and migration, and is required for normal wound healing. Plays a role in the oncogenic transformation of epithelial cells via repression of the TJ protein, occludin (OCLN) by inducing the up-regulation of a transcriptional repressor SNAI2/SLUG, which induces down-regulation of OCLN. Restricts caspase activation in response to selected stimuli, notably Fas stimulation, pathogen-mediated macrophage apoptosis, and erythroid differentiation. {ECO:0000269|PubMed:11427728, ECO:0000269|PubMed:11719507, ECO:0000269|PubMed:15385642, ECO:0000269|PubMed:15618521, ECO:0000269|PubMed:15849194, ECO:0000269|PubMed:16892053, ECO:0000269|PubMed:16924233, ECO:0000269|PubMed:9360956}.
Ensembl transtripts involved in fusion geneENST idsENST00000433332, ENST00000360413, 
ENST00000383836, 
ENST00000251849, 
ENST00000442415, ENST00000534997, 
ENST00000542177, 
Fusion gene scores for assessment (based on all fusion genes of FusionGDB 2.0)* DoF score12 X 10 X 10=120019 X 16 X 7=2128
# samples 1818
** MAII scorelog2(18/1200*10)=-2.73696559416621
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
log2(18/2128*10)=-3.56342933917152
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
Fusion gene context

PubMed: SRGAP3 [Title/Abstract] AND RAF1 [Title/Abstract] AND fusion [Title/Abstract]

Fusion neoantigen context

PubMed: SRGAP3 [Title/Abstract] AND RAF1 [Title/Abstract] AND neoantigen [Title/Abstract]

Most frequent breakpoint (based on all fusion genes of FusionGDB 2.0)SRGAP3(9290737)-RAF1(12625108), # samples:1
SRGAP3(9074334)-RAF1(12641309), # samples:1
Anticipated loss of major functional domain due to fusion event.SRGAP3-RAF1 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF.
SRGAP3-RAF1 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF.
SRGAP3-RAF1 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF.
SRGAP3-RAF1 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF.
SRGAP3-RAF1 seems lost the major protein functional domain in Hgene partner, which is a CGC due to the frame-shifted ORF.
SRGAP3-RAF1 seems lost the major protein functional domain in Hgene partner, which is a essential gene due to the frame-shifted ORF.
SRGAP3-RAF1 seems lost the major protein functional domain in Hgene partner, which is a tumor suppressor due to the frame-shifted ORF.
SRGAP3-RAF1 seems lost the major protein functional domain in Tgene partner, which is a CGC due to the frame-shifted ORF.
SRGAP3-RAF1 seems lost the major protein functional domain in Tgene partner, which is a IUPHAR drug target due to the frame-shifted ORF.
SRGAP3-RAF1 seems lost the major protein functional domain in Tgene partner, which is a kinase due to the frame-shifted ORF.
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types
** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10)

check button Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez
PartnerGeneGO IDGO termPubMed ID
HgeneSRGAP3

GO:0043547

positive regulation of GTPase activity

21148482

HgeneSRGAP3

GO:0046847

filopodium assembly

22559944

HgeneSRGAP3

GO:0051014

actin filament severing

21148482

HgeneSRGAP3

GO:0060996

dendritic spine development

22559944

HgeneSRGAP3

GO:2001223

negative regulation of neuron migration

22559944

TgeneRAF1

GO:0002227

innate immune response in mucosa

12860195

TgeneRAF1

GO:0019731

antibacterial humoral response

12860195

TgeneRAF1

GO:0043152

induction of bacterial agglutination

23992292

TgeneRAF1

GO:0045087

innate immune response

23992292

TgeneRAF1

GO:0050829

defense response to Gram-negative bacterium

23992292

TgeneRAF1

GO:0050830

defense response to Gram-positive bacterium

12860195|23992292

TgeneRAF1

GO:0061844

antimicrobial humoral immune response mediated by antimicrobial peptide

12860195



check button Four levels of functional features of fusion genes
Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr3:9290737/chr3:12625108)
- FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels.
- How to search
1. Put your fusion gene symbol.
2. Press the tab key until there will be shown the breakpoint information filled.
4. Go down and press 'Search' tab twice.
4. Go down to have the hyperlink of the search result.
5. Click the hyperlink.
6. See the FGviewer result for your fusion gene.
FGviewer

check buttonRetention analysis results of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features, are available here.

check buttonFusion gene breakpoints across SRGAP3 (5'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure

check buttonFusion gene breakpoints across RAF1 (3'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure


Top

Fusion Amino Acid Sequences


check buttonFusion information from ORFfinder translation from full-length transcript sequence from FusionPDB.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandSeq length
(transcript)
BP loci
(transcript)
Predicted start
(transcript)
Predicted stop
(transcript)
Seq length
(amino acids)
ENST00000383836SRGAP3chr39074334-ENST00000251849RAF1chr312641309-383719673382923861
ENST00000383836SRGAP3chr39074334-ENST00000442415RAF1chr312641309-364019673382923861
ENST00000383836SRGAP3chr39074334-ENST00000534997RAF1chr312641309-317119673382923861
ENST00000383836SRGAP3chr39074334-ENST00000542177RAF1chr312641309-310519673382923861

check buttonDeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandNo-coding scoreCoding score
ENST00000383836ENST00000251849SRGAP3chr39074334-RAF1chr312641309-0.0029715990.9970284
ENST00000383836ENST00000442415SRGAP3chr39074334-RAF1chr312641309-0.0046868190.99531317
ENST00000383836ENST00000534997SRGAP3chr39074334-RAF1chr312641309-0.0043996660.99560034
ENST00000383836ENST00000542177SRGAP3chr39074334-RAF1chr312641309-0.0045025350.99549747

check button Predicted full-length fusion amino acid sequences. For individual full-length fusion transcript sequence from FusionPDB, we ran ORFfinder and chose the longest ORF among all the predicted ones.

Get the fusion protein sequences from here.

Fusion protein sequence information is available in the fasta format.
>FusionGDB ID_FusionGDB isoform ID_FGname_Hgene_Hchr_Hbp_Henst_Tgene_Tchr_Tbp_Tenst_length(fusion AA) seq_BP

Top

Fusion Protein Breakpoint Sequences for SRGAP3-RAF1

check button +/-13 AA sequence from the breakpoints of the fusion protein sequences.
HgeneHchrHbpTgeneTchrTbpLength(fusion protein)BP in fusion proteinPeptide
SRGAP3chr39074334RAF1chr3126413091967543HKLFNGSMEAFIKRPRGQRDSSYYWE

Top

Potential FusionNeoAntigen Information of SRGAP3-RAF1 in HLA I

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.
SRGAP3-RAF1_9074334_12641309.msa

check button Potential FusionNeoAntigen Information
* We used NetMHCpan v4.1 (%rank<0.5) and deepHLApan v1.1 (immunogenic score>0.5)
Fusion geneHchrHbpTgeneTchrTbpHLA IFusionNeoAntigen peptideBinding scoreImmunogenic scoreNeoantigen start (at BP 13)Neoantigen end (at BP 13)
SRGAP3-RAF1chr39074334chr3126413091967HLA-A33:01FIKRPRGQR0.90670.50531019
SRGAP3-RAF1chr39074334chr3126413091967HLA-A33:05FIKRPRGQR0.90670.50531019
SRGAP3-RAF1chr39074334chr3126413091967HLA-A31:02AFIKRPRGQR0.90420.8944919
SRGAP3-RAF1chr39074334chr3126413091967HLA-A31:01AFIKRPRGQR0.93260.8821919
SRGAP3-RAF1chr39074334chr3126413091967HLA-C07:46KRPRGQRDSSY0.98570.74791223

Top

Potential FusionNeoAntigen Information of SRGAP3-RAF1 in HLA II

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.
SRGAP3-RAF1_9074334_12641309.msa

check button Potential FusionNeoAntigen Information
* We used NetMHCIIpan v4.1 (%rank<0.5).
Fusion geneHchrHbpTgeneTchrTbpHLA IIFusionNeoAntigen peptideNeoantigen start (at BP 13)Neoantigen end (at BP 13)
SRGAP3-RAF1chr39074334chr3126413091967DRB1-0901HKLFNGSMEAFIKRP015
SRGAP3-RAF1chr39074334chr3126413091967DRB1-0904HKLFNGSMEAFIKRP015
SRGAP3-RAF1chr39074334chr3126413091967DRB1-0905HKLFNGSMEAFIKRP015
SRGAP3-RAF1chr39074334chr3126413091967DRB1-0907HKLFNGSMEAFIKRP015
SRGAP3-RAF1chr39074334chr3126413091967DRB1-0909HKLFNGSMEAFIKRP015
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1102NGSMEAFIKRPRGQR419
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1102FNGSMEAFIKRPRGQ318
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1102GSMEAFIKRPRGQRD520
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1102LFNGSMEAFIKRPRG217
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1103NGSMEAFIKRPRGQR419
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1103FNGSMEAFIKRPRGQ318
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1111MEAFIKRPRGQRDSS722
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1114NGSMEAFIKRPRGQR419
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1114GSMEAFIKRPRGQRD520
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1114FNGSMEAFIKRPRGQ318
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1114MEAFIKRPRGQRDSS722
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1114SMEAFIKRPRGQRDS621
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1116NGSMEAFIKRPRGQR419
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1116FNGSMEAFIKRPRGQ318
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1116GSMEAFIKRPRGQRD520
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1116LFNGSMEAFIKRPRG217
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1120NGSMEAFIKRPRGQR419
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1120GSMEAFIKRPRGQRD520
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1120FNGSMEAFIKRPRGQ318
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1120MEAFIKRPRGQRDSS722
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1120SMEAFIKRPRGQRDS621
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1121NGSMEAFIKRPRGQR419
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1121FNGSMEAFIKRPRGQ318
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1121GSMEAFIKRPRGQRD520
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1121LFNGSMEAFIKRPRG217
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1136NGSMEAFIKRPRGQR419
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1136FNGSMEAFIKRPRGQ318
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1136GSMEAFIKRPRGQRD520
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1136LFNGSMEAFIKRPRG217
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1148NGSMEAFIKRPRGQR419
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1148FNGSMEAFIKRPRGQ318
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1155NGSMEAFIKRPRGQR419
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1155FNGSMEAFIKRPRGQ318
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1159NGSMEAFIKRPRGQR419
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1159FNGSMEAFIKRPRGQ318
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1163NGSMEAFIKRPRGQR419
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1163FNGSMEAFIKRPRGQ318
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1165NGSMEAFIKRPRGQR419
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1165FNGSMEAFIKRPRGQ318
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1165GSMEAFIKRPRGQRD520
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1165LFNGSMEAFIKRPRG217
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1168NGSMEAFIKRPRGQR419
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1168MEAFIKRPRGQRDSS722
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1168SMEAFIKRPRGQRDS621
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1168GSMEAFIKRPRGQRD520
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1168FNGSMEAFIKRPRGQ318
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1170NGSMEAFIKRPRGQR419
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1170FNGSMEAFIKRPRGQ318
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1170GSMEAFIKRPRGQRD520
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1170LFNGSMEAFIKRPRG217
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1176NGSMEAFIKRPRGQR419
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1176FNGSMEAFIKRPRGQ318
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1185NGSMEAFIKRPRGQR419
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1185FNGSMEAFIKRPRGQ318
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1186NGSMEAFIKRPRGQR419
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1186GSMEAFIKRPRGQRD520
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1186FNGSMEAFIKRPRGQ318
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1186MEAFIKRPRGQRDSS722
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1186SMEAFIKRPRGQRDS621
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1301NGSMEAFIKRPRGQR419
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1301FNGSMEAFIKRPRGQ318
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1301GSMEAFIKRPRGQRD520
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1301LFNGSMEAFIKRPRG217
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1302NGSMEAFIKRPRGQR419
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1302GSMEAFIKRPRGQRD520
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1302FNGSMEAFIKRPRGQ318
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1302MEAFIKRPRGQRDSS722
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1302SMEAFIKRPRGQRDS621
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1304NGSMEAFIKRPRGQR419
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1304FNGSMEAFIKRPRGQ318
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1308NGSMEAFIKRPRGQR419
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1308FNGSMEAFIKRPRGQ318
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1309NGSMEAFIKRPRGQR419
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1309FNGSMEAFIKRPRGQ318
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1315NGSMEAFIKRPRGQR419
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1315FNGSMEAFIKRPRGQ318
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1315GSMEAFIKRPRGQRD520
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1315LFNGSMEAFIKRPRG217
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1316NGSMEAFIKRPRGQR419
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1316GSMEAFIKRPRGQRD520
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1316FNGSMEAFIKRPRGQ318
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1316MEAFIKRPRGQRDSS722
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1316SMEAFIKRPRGQRDS621
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1317NGSMEAFIKRPRGQR419
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1317FNGSMEAFIKRPRGQ318
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1317LFNGSMEAFIKRPRG217
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1317GSMEAFIKRPRGQRD520
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1319NGSMEAFIKRPRGQR419
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1319FNGSMEAFIKRPRGQ318
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1319GSMEAFIKRPRGQRD520
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1319LFNGSMEAFIKRPRG217
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1320NGSMEAFIKRPRGQR419
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1320FNGSMEAFIKRPRGQ318
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1320GSMEAFIKRPRGQRD520
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1320LFNGSMEAFIKRPRG217
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1322NGSMEAFIKRPRGQR419
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1322FNGSMEAFIKRPRGQ318
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1322GSMEAFIKRPRGQRD520
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1322LFNGSMEAFIKRPRG217
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1323NGSMEAFIKRPRGQR419
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1323GSMEAFIKRPRGQRD520
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1323FNGSMEAFIKRPRGQ318
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1323MEAFIKRPRGQRDSS722
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1323SMEAFIKRPRGQRDS621
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1324NGSMEAFIKRPRGQR419
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1324FNGSMEAFIKRPRGQ318
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1327NGSMEAFIKRPRGQR419
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1327FNGSMEAFIKRPRGQ318
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1327LFNGSMEAFIKRPRG217
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1327GSMEAFIKRPRGQRD520
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1329NGSMEAFIKRPRGQR419
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1329MEAFIKRPRGQRDSS722
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1329SMEAFIKRPRGQRDS621
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1329GSMEAFIKRPRGQRD520
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1329FNGSMEAFIKRPRGQ318
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1334NGSMEAFIKRPRGQR419
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1334GSMEAFIKRPRGQRD520
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1334FNGSMEAFIKRPRGQ318
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1334MEAFIKRPRGQRDSS722
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1334SMEAFIKRPRGQRDS621
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1335NGSMEAFIKRPRGQR419
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1335FNGSMEAFIKRPRGQ318
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1335GSMEAFIKRPRGQRD520
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1335LFNGSMEAFIKRPRG217
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1336NGSMEAFIKRPRGQR419
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1339NGSMEAFIKRPRGQR419
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1339GSMEAFIKRPRGQRD520
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1339FNGSMEAFIKRPRGQ318
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1339MEAFIKRPRGQRDSS722
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1339SMEAFIKRPRGQRDS621
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1341NGSMEAFIKRPRGQR419
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1341GSMEAFIKRPRGQRD520
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1341MEAFIKRPRGQRDSS722
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1341FNGSMEAFIKRPRGQ318
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1343NGSMEAFIKRPRGQR419
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1343FNGSMEAFIKRPRGQ318
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1351NGSMEAFIKRPRGQR419
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1351FNGSMEAFIKRPRGQ318
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1351GSMEAFIKRPRGQRD520
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1351LFNGSMEAFIKRPRG217
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1352NGSMEAFIKRPRGQR419
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1352FNGSMEAFIKRPRGQ318
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1352GSMEAFIKRPRGQRD520
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1352LFNGSMEAFIKRPRG217
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1353NGSMEAFIKRPRGQR419
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1353FNGSMEAFIKRPRGQ318
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1353GSMEAFIKRPRGQRD520
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1353LFNGSMEAFIKRPRG217
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1357NGSMEAFIKRPRGQR419
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1357FNGSMEAFIKRPRGQ318
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1357GSMEAFIKRPRGQRD520
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1357LFNGSMEAFIKRPRG217
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1359NGSMEAFIKRPRGQR419
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1359FNGSMEAFIKRPRGQ318
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1359GSMEAFIKRPRGQRD520
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1359LFNGSMEAFIKRPRG217
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1361NGSMEAFIKRPRGQR419
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1361FNGSMEAFIKRPRGQ318
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1361GSMEAFIKRPRGQRD520
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1361LFNGSMEAFIKRPRG217
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1363MEAFIKRPRGQRDSS722
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1364NGSMEAFIKRPRGQR419
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1364FNGSMEAFIKRPRGQ318
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1364GSMEAFIKRPRGQRD520
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1364LFNGSMEAFIKRPRG217
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1368NGSMEAFIKRPRGQR419
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1368FNGSMEAFIKRPRGQ318
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1368GSMEAFIKRPRGQRD520
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1368LFNGSMEAFIKRPRG217
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1369NGSMEAFIKRPRGQR419
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1369FNGSMEAFIKRPRGQ318
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1369GSMEAFIKRPRGQRD520
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1369LFNGSMEAFIKRPRG217
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1370NGSMEAFIKRPRGQR419
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1370FNGSMEAFIKRPRGQ318
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1371NGSMEAFIKRPRGQR419
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1371FNGSMEAFIKRPRGQ318
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1371GSMEAFIKRPRGQRD520
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1371LFNGSMEAFIKRPRG217
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1372NGSMEAFIKRPRGQR419
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1372FNGSMEAFIKRPRGQ318
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1373NGSMEAFIKRPRGQR419
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1373GSMEAFIKRPRGQRD520
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1373FNGSMEAFIKRPRGQ318
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1373MEAFIKRPRGQRDSS722
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1373SMEAFIKRPRGQRDS621
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1374NGSMEAFIKRPRGQR419
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1374GSMEAFIKRPRGQRD520
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1374FNGSMEAFIKRPRGQ318
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1374MEAFIKRPRGQRDSS722
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1374SMEAFIKRPRGQRDS621
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1375NGSMEAFIKRPRGQR419
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1376NGSMEAFIKRPRGQR419
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1378NGSMEAFIKRPRGQR419
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1378FNGSMEAFIKRPRGQ318
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1378GSMEAFIKRPRGQRD520
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1378LFNGSMEAFIKRPRG217
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1379NGSMEAFIKRPRGQR419
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1379FNGSMEAFIKRPRGQ318
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1379GSMEAFIKRPRGQRD520
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1379LFNGSMEAFIKRPRG217
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1380NGSMEAFIKRPRGQR419
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1380FNGSMEAFIKRPRGQ318
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1380GSMEAFIKRPRGQRD520
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1380LFNGSMEAFIKRPRG217
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1383NGSMEAFIKRPRGQR419
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1383FNGSMEAFIKRPRGQ318
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1383GSMEAFIKRPRGQRD520
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1383LFNGSMEAFIKRPRG217
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1384NGSMEAFIKRPRGQR419
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1384FNGSMEAFIKRPRGQ318
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1387NGSMEAFIKRPRGQR419
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1387FNGSMEAFIKRPRGQ318
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1387GSMEAFIKRPRGQRD520
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1387LFNGSMEAFIKRPRG217
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1391NGSMEAFIKRPRGQR419
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1391FNGSMEAFIKRPRGQ318
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1391GSMEAFIKRPRGQRD520
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1391LFNGSMEAFIKRPRG217
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1392NGSMEAFIKRPRGQR419
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1392FNGSMEAFIKRPRGQ318
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1392GSMEAFIKRPRGQRD520
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1392LFNGSMEAFIKRPRG217
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1393NGSMEAFIKRPRGQR419
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1393FNGSMEAFIKRPRGQ318
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1396MEAFIKRPRGQRDSS722
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1396NGSMEAFIKRPRGQR419
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1396GSMEAFIKRPRGQRD520
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1396SMEAFIKRPRGQRDS621
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1397NGSMEAFIKRPRGQR419
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1397GSMEAFIKRPRGQRD520
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1397FNGSMEAFIKRPRGQ318
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1397MEAFIKRPRGQRDSS722
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1397SMEAFIKRPRGQRDS621
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1398NGSMEAFIKRPRGQR419
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1398FNGSMEAFIKRPRGQ318
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1398GSMEAFIKRPRGQRD520
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1398LFNGSMEAFIKRPRG217
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1399NGSMEAFIKRPRGQR419
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1399GSMEAFIKRPRGQRD520
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1399FNGSMEAFIKRPRGQ318
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1399MEAFIKRPRGQRDSS722
SRGAP3-RAF1chr39074334chr3126413091967DRB1-1399SMEAFIKRPRGQRDS621

Top

Fusion breakpoint peptide structures of SRGAP3-RAF1

check button3D structures of the fusion breakpoint peptide of 14AA sequence that have potential fusion neoantigens
* The minimum length of the amino acid sequence in RoseTTAFold is 14AA. Here, we predicted the 14AA fusion protein breakpoint sequence not the fusion neoantigen peptide, which is shorter than 14 AA.
File nameBPseqHgeneTgeneHchrHbpTchrTbpAAlen
8820SMEAFIKRPRGQRDSRGAP3RAF1chr39074334chr3126413091967

Top

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D of SRGAP3-RAF1

check buttonVirtual screening between 25 HLAs (from PDB) and FusionNeoAntigens
* We used Glide to predict the interaction between HLAs and neoantigens.
HLA allelePDB IDFile nameBPseqDocking scoreGlide score
HLA-B14:023BVN8820SMEAFIKRPRGQRD-7.9962-8.1096
HLA-B14:023BVN8820SMEAFIKRPRGQRD-5.70842-6.74372
HLA-B52:013W398820SMEAFIKRPRGQRD-6.83737-6.95077
HLA-B52:013W398820SMEAFIKRPRGQRD-4.4836-5.5189
HLA-A11:014UQ28820SMEAFIKRPRGQRD-10.0067-10.1201
HLA-A11:014UQ28820SMEAFIKRPRGQRD-9.03915-10.0745
HLA-A24:025HGA8820SMEAFIKRPRGQRD-6.56204-6.67544
HLA-A24:025HGA8820SMEAFIKRPRGQRD-5.42271-6.45801
HLA-B44:053DX88820SMEAFIKRPRGQRD-7.85648-8.89178
HLA-B44:053DX88820SMEAFIKRPRGQRD-5.3978-5.5112
HLA-A02:016TDR8820SMEAFIKRPRGQRD-3.37154-4.40684

Top

Vaccine Design for the FusionNeoAntigens of SRGAP3-RAF1

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-Is.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptide sequenceFusionNeoAntigen RNA sequence
SRGAP3-RAF1chr39074334chr3126413091019FIKRPRGQRTTCATTAAGAGGCCTCGTGGACAGAGA
SRGAP3-RAF1chr39074334chr3126413091223KRPRGQRDSSYAAGAGGCCTCGTGGACAGAGAGATTCAAGCTAT
SRGAP3-RAF1chr39074334chr312641309919AFIKRPRGQRGCATTCATTAAGAGGCCTCGTGGACAGAGA

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-IIs.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptideFusionNEoAntigen RNA sequence
SRGAP3-RAF1chr39074334chr312641309015HKLFNGSMEAFIKRPCATAAACTCTTTAACGGCAGTATGGAAGCATTCATTAAGAGGCCT
SRGAP3-RAF1chr39074334chr312641309217LFNGSMEAFIKRPRGCTCTTTAACGGCAGTATGGAAGCATTCATTAAGAGGCCTCGTGGA
SRGAP3-RAF1chr39074334chr312641309318FNGSMEAFIKRPRGQTTTAACGGCAGTATGGAAGCATTCATTAAGAGGCCTCGTGGACAG
SRGAP3-RAF1chr39074334chr312641309419NGSMEAFIKRPRGQRAACGGCAGTATGGAAGCATTCATTAAGAGGCCTCGTGGACAGAGA
SRGAP3-RAF1chr39074334chr312641309520GSMEAFIKRPRGQRDGGCAGTATGGAAGCATTCATTAAGAGGCCTCGTGGACAGAGAGAT
SRGAP3-RAF1chr39074334chr312641309621SMEAFIKRPRGQRDSAGTATGGAAGCATTCATTAAGAGGCCTCGTGGACAGAGAGATTCA
SRGAP3-RAF1chr39074334chr312641309722MEAFIKRPRGQRDSSATGGAAGCATTCATTAAGAGGCCTCGTGGACAGAGAGATTCAAGC

Top

Information of the samples that have these potential fusion neoantigens of SRGAP3-RAF1

check button These samples were reported as having these fusion breakpoints. For individual breakpoints, we checked the open reading frames considering multiple gene isoforms and chose the in-frame fusion genes only. Then, we made fusion protein sequences and predicted the fusion neoantigens. These fusion-positive samples may have these potential fusion neoantigens.
Cancer typeFusion geneHchrHbpHenstTchrTbpTenstSample
N/ASRGAP3-RAF1chr39074334ENST00000383836chr312641309ENST00000251849FM209427

Top

Potential target of CAR-T therapy development for SRGAP3-RAF1

check button Predicted 3D structure. We used RoseTTAFold.

check buttonRetention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, to provide the retention of the transmembrane domain, we only show the protein feature retention information of those transmembrane features


* Minus value of BPloci means that the break point is located before the CDS.
- In-frame and retained 'Transmembrane'.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenProtein featureProtein feature note

check button Subcellular localization prediction of the transmembrane domain retained fusion proteins
* We used DeepLoc 1.0. The order of the X-axis of the barplot is as follows: Entry_ID, Localization, Type, Nucleus, Cytoplasm, Extracellular, Mitochondrion, Cell_membrane, Endoplasmic_reticulum, Plastid, Golgi.apparatus, Lysosome.Vacuole, Peroxisome. Y-axis is the output score of DeepLoc. Clicking the image will open a new tab with a large image.
HgeneHchrHbpHenstTgeneTchrTbpTenstDeepLoc result

Top

Related Drugs to SRGAP3-RAF1

check button Drugs used for this fusion-positive patient.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDrugSourcePMID

Top

Related Diseases to SRGAP3-RAF1

check button Diseases that have this fusion gene.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDiseaseSourcePMID

check button Diseases associated with fusion partners.
(DisGeNet 4.0)
PartnerGeneDisease IDDisease name# pubmedsSource
TgeneRAF1C0028326Noonan Syndrome10CLINGEN;CTD_human;GENOMICS_ENGLAND;ORPHANET
TgeneRAF1C0175704LEOPARD Syndrome7CLINGEN;CTD_human;GENOMICS_ENGLAND
TgeneRAF1C1969057Noonan Syndrome 54CTD_human;GENOMICS_ENGLAND;UNIPROT
TgeneRAF1C1969056LEOPARD SYNDROME 23CTD_human;GENOMICS_ENGLAND;UNIPROT
TgeneRAF1C0007194Hypertrophic Cardiomyopathy2CTD_human
TgeneRAF1C0041409Turner Syndrome, Male2CTD_human
TgeneRAF1C1519086Pilomyxoid astrocytoma2ORPHANET
TgeneRAF1C1527404Female Pseudo-Turner Syndrome2CTD_human
TgeneRAF1C4551472Hypertrophic obstructive cardiomyopathy2CTD_human
TgeneRAF1C4551602Noonan Syndrome 12CTD_human
TgeneRAF1C0006142Malignant neoplasm of breast1CTD_human
TgeneRAF1C0007131Non-Small Cell Lung Carcinoma1CTD_human
TgeneRAF1C0007193Cardiomyopathy, Dilated1CTD_human
TgeneRAF1C0017638Glioma1CTD_human
TgeneRAF1C0020429Hyperalgesia1CTD_human
TgeneRAF1C0022665Kidney Neoplasm1CTD_human
TgeneRAF1C0023903Liver neoplasms1CTD_human
TgeneRAF1C0024121Lung Neoplasms1CTD_human
TgeneRAF1C0242379Malignant neoplasm of lung1CTD_human
TgeneRAF1C0259783mixed gliomas1CTD_human
TgeneRAF1C0340427Familial dilated cardiomyopathy1ORPHANET
TgeneRAF1C0345904Malignant neoplasm of liver1CTD_human
TgeneRAF1C0345967Malignant mesothelioma1CTD_human
TgeneRAF1C0458247Allodynia1CTD_human
TgeneRAF1C0555198Malignant Glioma1CTD_human
TgeneRAF1C0587248Costello syndrome (disorder)1CLINGEN
TgeneRAF1C0678222Breast Carcinoma1CTD_human
TgeneRAF1C0740457Malignant neoplasm of kidney1CTD_human
TgeneRAF1C0751211Hyperalgesia, Primary1CTD_human
TgeneRAF1C0751212Hyperalgesia, Secondary1CTD_human
TgeneRAF1C0751213Tactile Allodynia1CTD_human
TgeneRAF1C0751214Hyperalgesia, Thermal1CTD_human
TgeneRAF1C1257931Mammary Neoplasms, Human1CTD_human
TgeneRAF1C1275081Cardio-facio-cutaneous syndrome1CLINGEN
TgeneRAF1C1449563Cardiomyopathy, Familial Idiopathic1CTD_human
TgeneRAF1C1458155Mammary Neoplasms1CTD_human
TgeneRAF1C2936719Mechanical Allodynia1CTD_human
TgeneRAF1C4014656CARDIOMYOPATHY, DILATED, 1NN1CTD_human;UNIPROT
TgeneRAF1C4551484Leopard Syndrome 11CTD_human;GENOMICS_ENGLAND
TgeneRAF1C4704874Mammary Carcinoma, Human1CTD_human
TgeneRAF1C4721610Carcinoma, Ovarian Epithelial1CTD_human